4DMT Highlights Robust and Durable Clinical Activity for 4D-150 and Design of 4FRONT Phase 3 Program at 4D-150 Wet AMD Development Day
D-150 demonstrated robust and durable clinical activity across all wet age-related macular degeneration (wet AMD) patient populations based on ...
Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024
Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental ...
I felt like a balding has-been – a hair transplant restored my confidence
When Dom noticed his bald patch, he resorted to having a hair transplant in Turkey. Here’s how it went – and what you should ...
PharmiWeb10d
Gilead and Genesis Therapeutics Announce Strategic Collaboration to Discover and Develop Novel Therapies
Gilead Sciences, Inc. (Nasdaq: GILD) and Genesis Therapeutics, Inc. announced today that the companies have entered into a strategic collaboration to discover and develop novel, small molecule ...
Macrogenics Announces Updated Efficacy & Safety Data From TAMARACK Phase 2 Study Of Vobra Duo In Mcrpc Patients At ESMO Congress 2024
Encouraging antitumor activity demonstrated with vobra duo as measured by 6-month landmark rPFS rate and ORR <li /> Patients remained o ...
Business Wire7d
Exelixis Presents Final Overall Survival Results from Phase 3 CONTACT-02 Pivotal Study Evaluating Cabozantinib in Combination with an Immune Checkpoint Inhibitor in Metastatic ...
“I believe there is a critical need for novel agents with a new mechanism of action that are ... especially in the subset of patients with liver metastasis, reinforce the therapeutic potential of ...
Telix Pharmaceuticals Limited: 'Highly Accurate': Telix's Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that primary results from its Phase III ZIRCON[1] trial have ...
Australian Broadcasting Corporation4d
Program: Hezbollah vows revenge for exploding pagers
They are the agent for all our products. They also produced a page using our brand name. They pay us for using our logo. We have contracts ready ... the drug that could help her is approved by the ...
News Medical on MSN13d
New chemical modification reduces off-target effects in siRNA drugs
Small interfering RNA (siRNA) drugs are a class of therapeutic agents that silence specific genes associated with inherited diseases.
News Medical on MSN5d
Ohio State's novel DHODH inhibitor enters first human trials
A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the patient's bedside as part of a clinical trial.
Etanercept Biosimilar Insight Market Report 2024: Pipeline Analysis, Therapeutic Assessment, Sales Assessment, Unmet Needs, and Impact of Drugs
The "Etanercept - Biosimilar Insight, 2024" report has been added to ResearchAndMarkets.com's offering.This "Etanercept - Biosimilar Insight, 2024" report provides comprehensive insights about 15+ ...
Medscape4d
Therapeutic Use of Levocloperastine as an Antitussive Agent
There was no evidence of clinically significant central adverse events, whereas drowsiness, dry mouth and nausea were reported with comparator agents (levodropropizine, codeine, DL-cloperastine).